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Abstract 
We have investigated the interaction of S-100 proteins (/3 and/or or) and annexin II2-pl 12 with glial fibrillary acidic protein (GFAP) 
and desmin to have further information on the mechanisms whereby S-100 proteins and annexin II2-pl 12 affect assembly/disassembly of 
GFAP and desmin intermediate filaments (IFs). Analyses were conducted on either native IF subunits, GFAP or desmin rod domain, or 
headless GFAP or desmin. Our data indicate that: (i) S-100 proteins bind to GFAP and desmin N-terminal head domain; (ii) annexin 
II2-pl 12 binds to GFAP rod domain; (iii) annexin II2-pl 1 z does not interact with desmin nor affects desmin assembly. The present data 
suggest that the ability of S-100 proteins to inhibit GFAP and desmin assemblies and to promote the disassembly of preformed GFAP and 
desmin IFs depends on occupation of a site on the N-terminal head domain of these IF subunit. It is known that the N-terminal head 
domain is critical for the progression from the stage of GFAP and desmin dimers/tetramers to that of large oligomers. On the other hand, 
the ability of annexin II2- p 112 to stimulate GFAP assembly under conditions where this latter is normally hampered (e.g., at alkaline pH 
values) might depend on annexin II2-pl lz-induced changes in the structure of GFAP rod domain, possibly as a consequence of charge 
modifications. By contrast, the inability of annexin II2-pll 2 to bind to desmin would depend on desmin resistance to charge 
modifications. 
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1. Introduction 
Intermediate filaments (IFs) are a major cytoskeleton 
constituent implicated in the mechanical properties of eu- 
karyotic cells. Their activity is dynamically regulated via 
assembly and disassembly (see Refs. [1-7] for reviews). 
Phosphorylation has been identified as one mechanism of 
regulating IF activity; phosphorylation of preformed IFs 
results in IF disassembly and phosphorylation of unassem- 
bled IF subunits results in assembly-incompetent subunits 
Abbreviations: IF, intermediate filament; GFAP, glial fibrillary acidic 
protein; DTT, dithiothreitol; DSS, disuccinimidyl suberate; PMSF, 
phenylmethylsulfonyl fluoride; TPCK, N-tosyl-L-phenylalaninchlor-meth- 
ylketone; PAGE, polyacrylamide gel electrophoresis 
* Corresponding author. Fax +39 75 5853451. 
[1-7]. Selective interaction with accessory proteins repre- 
sents another mechanism by which the activity of cyto- 
skeletal elements can be selectively modulated (see Refs. 
[1,8-12] for reviews). In fact, we reported recently that 
proteins of the S-100 family (see Refs. [13,14]), S-100ao, 
S-100a and S-100b, bind to and inhibit the self-assembly 
of (i) glial fibrillary acidic protein (GFAP) into type III IFs 
specific to glial cells and (ii) desmin into type III IFs 
specific to mature muscle cells [15,16]. The modulatory 
effects of the above S-100 proteins on IF assembly are 
strictly Ca2+-dependent [15,16]. In addition we have re- 
ported that calcium-regulated proteins (i.e. annexin II 2-P 112 
heterotetramer) can stimulate GFAP assembly [17]. There- 
fore, both the annexin II2-pl 12 heterotetramer, a complex 
of the CaZ+-dependent phospholipid- and membrane-bind- 
ing protein annexin 112 and the S-100-1ike protein pl 1 
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[18,19]; and the Ca2+-binding protein S-100 (a and/3) are 
capable of modulating the assembly/disassembly of type 
III IFs. Interestingly, association of these accessory pro- 
teins with IF proteins induce opposing regulatory effects, 
i.e. promoting assembly or disassembly, respectively. 
In the present work we investigated further the interac- 
tions between the calcium-dependent accessory proteins 
S-100 (/3 and/or ~) and annexin II2-pll 2 with the IF 
proteins GFAP and desmin with the goal of obtaining an 
understanding of the molecular mechanisms whereby these 
proteins modulate the assembly properties of type III IFs. 
Our results suggest that S-100 proteins inhibit GFAP and 
desmin assemblies by interfering with the natural progres- 
sion from the stage of dimers/tetramers to that of larger 
oligomers, by binding to the N-terminal head domain of 
both GFAP and desmin, whereas annexin II2-pl 12 stimu- 
lates filament assembly via interaction with the rod do- 
main. The present data on S-100 protein/GFAP interac- 
tion complement data presented in the preceding report 
[20], which documents the homology of a known peptide 
inhibitor of S-100 (a and /3) (TRTK-12) [21,22] to a 
segment contained in the N-terminal head domain of GFAP 
and the ability of this peptide to block the S-100 protein 
effects on GFAP assembly-disassembly. 
used in the present study was a generous gift from Dr. 
Volker Gerke, Muenster, Germany. 
2.2. Cross-linking experiments 
GFAP or desmin was incubated at room temperature for 
30 min in the absence of presence of either (i) S-100 (/3 
and/or a), (ii) annexin II2-Pl 12, or (iii) S-100 proteins ( 
and /3) plus annexin II2-pll 2 in 0.1 ml of 20 mM 
Tris-HC1, pH 7.4, 1 mM MgCI 2, 1 mM DTT and ~ 10 
/xM free Ca 2÷ after which the bifunctional cross-linker 
DSS was added to a final concentration f 0.5 raM. After 
10 min, the reaction was terminated by the addition of 
SDS (2% final) and 2-mercaptoethanol (5% final). Sam- 
pies were analyzed by SDS-PAGE [29] (10% acrylamide). 
Gels were either transblotted onto nitrocellulose paper for 
immunoblotting [30] with an anti-S-100 (a and /3) anti- 
serum or an anti-annexin II antiserum; or stained with 
Coomassie blue. Analogous experiments were performed 
with either a-chymotrypsin-treated GFAP or desmin, and 
with either thrombin-treated GFAP or desmin. 
2.3. Generation of proteolytic fragments of GFAP and 
desmin 
2. Materials and methods 
Dithiothreitol (DTT), phenylmethylsulfonyl fluoride 
(PMSF), N-tosyl-L-phenylalaninchlor-methylketone 
(TPCK), a-chymotrypsin, and thrombin were obtained 
from Sigma; disuccinimidyl suberate (DSS) from Pierce. 
Also from Sigma were the molecular weight standards 
(myosin [205 kDa], /3-galactosidase [116 kDa], phosphory- 
lase B [97.4 kDa], bovine serum albumin [66 kDa], ovalbu- 
min [45 kDa], carbonic anhydrase [29 kDa]). All other 
products were analytical grade reagents from Sigma, Fluka, 
Bio-Rad, BDH, DBA, or Carlo Erba. 
2.1. Purification of protein, 
S-100 protein and GFAP were purified from bovine 
brain [23] and spinal cord [24], respectively. The S-100 
protein fraction used in cross-linking studies with GFAP 
was composed of ~ 20% S-100a (S-100A1) and ~ 80% 
S-100/3 (S-100B). This S-100 fraction was not further 
fractionated since both proteins proved equipotent in bind- 
ing to and affecting the assembly of GFAP [15]. S-100ao 
(aa  or S-100A12) was purified from porcine heart as 
described [25]. Desmin was purified from chicken gizzard 
as reported [26]. Annexin II2-pll 2 was purified from 
bovine lung [27], essentially as described [28]. A commer- 
cial polyclonal anti-bovine brain S-100 protein antiserum 
raised in rabbits and recognizing both S-100a and S-100/3 
was obtained from Dako. The anti-annexin II antiserum 
Treatment of either GFAP or desmin with a- 
chymotrypsin (1:400, wt:wt.) removed both the N- and 
C-terminal ends yielding an assembly incompetent GFAP 
or desmin rod domain [31]. Treatment of either GFAP or 
desmin with thrombin (1:1000, w/w) removed N-terminal 
end of either protein yielding a similarly assembly-incom- 
petent GFAP or desmin fragments [32]. Irrespective of the 
proteolytic fragmentation protocol employed, after block- 
ade of enzymes with a mixture of 0.5 mM PMSF and 0.1 
mM TPCK (30 min at room temperature), IF fragments 
were purified by ion-exchange chromatography, as previ- 
ously reported [31,32]. Results obtained in cross-linking 
experiments were independent of whether purified IF sub- 
unit fragments or PMSF and TPCK proteolytic digestion 
mixtures were employed. Mock digestion mixtures, in 
which each of the above proteases was incubated with the 
cocktail of inhibitors prior to incubation with S-100 or 
annexin II2-pll 2 protein gave negative results, i.e. both 
the resulting electrophoretic pattern and immunoblots indi- 
cated that PMSF and TPCK efficaciously blocked prote- 
olytic activity (not shown). 
2.4. Other procedures 
The free Ca 2+ concentration was calculated as reported 
[33]. The following molecular weights were employed: 21 
kDa for S-100 protein, 50 kDa for GFAP, 38 kDa for the 
GFAP rod domain, 45 kDa for headless GFAP, 55 kDa for 
desmin, and 90 kDa for the annexin II2-pll z hetero- 
tetramer. 
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3. Resu l ts  
3.1. S-100 protein (mixture of S-lOOa and S-100~) inter- 
feres with GFAP oligomerization beyond the tetrameric 
stage 
Exposure of GFAP to DSS resulted in a decrease in the 
amount of monomeric GFAP and in the formation of a 
l imited amount of low molecular weight complexes (up to 
220-250 kDa) and a large amount of high molecular 
weight complexes that failed to enter the stacking gel (Fig. 
1A, lane c). When cross-l inking experiments were per- 
formed in the presence of S-100 protein and Ca 2+ the 
amounts of monomeric GFAP and low molecular weight 
GFAP oligomers increased, the amounts of the high 
molecular weight GFAP oligomers decreased and a 60-kDa 
GFAP:S-100 (monomer:monomer)  complex [15] was ob- 
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Fig. 1. Interaction of S-100 (or and /3) with native GFAP as investigated 
by chemical cross-linking. (A) GFAP (28 /zM) was incubated as de- 
scribed in Section 2 in the absence (lane c) or presence (lane d) of 15 tzM 
S-100 (or and /3) before addition of DSS to 0.5 mM. Incubation was 
continued for 15 min before blocking the reaction with SDS plus 2-mer- 
captoethanol. Samples were boiled for 5 min and subjected to SDS-PAGE 
(10% acrylamide). Gels were stained with Coomassie blue. Lane a: tool 
wt. standards (from top to bottom, 205 kDa, 116 kDa, 97.4 kDa, 66 kDa, 
45 kDa, 29 kDa); Lane b: GFAP not exposed to DSS. (B) Conditions 
were as described for lane d in panel A. After SDS-PAGE, proteins were 
transblotted onto nitrocellulose for immunoblotting with a commercial 
anti-S-100 (a and /3) antiserum. In A and B, the position of large 
DSS-induced GFAP oligomers that fail to enter the stacking gel is 
indicated by (El); the low molecular weight GFAP oligomers formed 
upon exposure to DSS are indicated by ( [ ); a 70-kDa GFAP:(S-100) 2 
complex is indicated by (•  •);  the 60-kDa GFAP:S-100 (monomer) 
complex is indicated by (•) ;  the position of uncomplexed (monomeric) 
GFAP is indicated by (1~); and the position of monomeric S-100 (or and 
/3) is indicated by (~) .  Note that upon exposure to DSS S-100 (or and 
/3) forms dimers, trimers and tetramers, that are barely visible in SDS 
gels (see lane d in panel A) but are strongly immunoreactive (panel B). 
Additions are marked by (O). 
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Fig. 2. DSS-induced cross-linking of native GFAP in the absence or 
presence of S-100 (a and /3) at increasing urea concentrations. (A) 
Conditions were as in Fig. 1, except that urea was included in the 
incubation mixtures at the final concentrations indicated and S-100 (or 
and /3) was used at 8 p.M. SDS gels were stained with Coomassie blue. 
(B) Condition were as in panel A, except hat after SDS-PAGE proteins 
were transblotted onto nitrocellulose paper for immunostaining with an 
anti-S-100 (or and /3) antiserum. The lane corresponding to lane a in A 
was not included. See Fig. 1 for symbol legend. Additions are marked by 
(O). DSS was present throughout. 
served (Fig. 1 A, lane d). Western blot analyses performed 
with an anti-S-100 antiserum documented the presence of 
S-100 immunoreactivity in association with the 60-kDa 
complex and several low molecular weight GFAP 
oligomers (GFAP dimers, trimers and tetramers), but not 
with high molecular weight GFAP oligomers (Fig. 1B). 
These results suggested that S-100 protein interfered with 
the ability of DSS to cross-l ink GFAP into large oligomers 
by binding to and stabil izing intermediate oligomeric om- 
plexes [1,7]. To investigate further whether the f i lamentous 
assembly of GFAP is inhibited by stabilization of 
d imers/tetramers by S-100 protein we repeated the above 
cross-l inking experiments in the presence of increasing 
concentrations of urea. 
It is known that IF subunits are present as tetramers in 
buffers of low ionic strength containing up to 4 M urea, 
whereas in higher urea concentrations tetramers dissociate 
into monomers [34]. Cross-l inking analyses gels revealed 
that in the absence of S-100 protein and in the presence of 
increasing concentrations of urea (up to 4 M urea) low 
molecular weight GFAP oligomers could be still generated 
fol lowing exposure to DSS (Fig. 2A). With increasing urea 
concentrations a progressive increase in the amount of 
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GFAP dimers and a concomitant decrease in the amount of 
GFAP trimers and tetramers and disappearance of large 
GFAP oligomers was observed. At urea concentrations of 
6-8 M urea a striking reduction in the amount of low 
molecular weight GFAP oligomers was observed along 
with an expected increase in monomeric GFAP content 
and absence of large GFAP oligomers (Fig. 2A). When the 
identical cross-linking experiment was performed in the 
presence of S-100 protein the intensity of the 60-kDa band 
was unaffected at 6 M urea, whereas it was significantly 
reduced in the presence of 8 M urea (Fig. 2A). Finally, in 
the presence of urea concentrations, up to 4 M, and S-100 
protein the intensity of GFAP dimers appeared to increase, 
while that of GFAP trimers remained stable and that of 
GFAP tetramers decreased, atleast when compared to their 
respective non-S-100 controls (Fig. 2A). 
Immunoblot analyses determined that urea produced a
dose-dependent decrease in S-100 association with the low 
molecular weight GFAP otigomers and to a lesser extent 
the 60-kDa complex. In accordance with data in Fig. 2A, 
at 6-8 M urea the S-100 immunoreactivity was no longer 
associated with any of the low molecular weight GFAP 
oligomers (dimers, trimer~,; and tetramers), whereas im- 
munostaining of the 60-kDa complex was still clearly 
evident. This indicated to us that S-100 protein remained 
associated with (monomeric) GFAP in the presence of 6-8 
M urea and formed a 1:1 S-100 subunit:GFAP complex. 
This suggests that S-100 protein interacts pecifically with 
a sequence contained in GFAP monomer which is stable 
even at urea concentrations at which solely GFAP 
monomers exist in solution (6-8 M urea). Consistent with 
this observation is the failure of S-100 association with 
GFAP oligomers to increase upon exposure to increasing 
urea concentrations (up to 4 M), treatments which did 
increase the quantity of low molecular weight oligomers 
present. This suggests that S-100 protein might act by 
disrupting dimer/dimer associations via interaction with a 
discrete sequence contained within GFAP, but that this 
association domain is masked in tetrameric and oligomeric 
structures. 
Fig. 1B and 2B also show that a GFAP:S-100 protein 
complex of ca. 70 kDa formed upon exposure to DSS. 
This complex probably results from DSS-induced complex 
of one mol of GFAP with one mol of S-100 dimer. 
Based upon these observations we concluded that S-100 
protein binds to a site on GFAP that is implicated in the 
supramolecular o ganization of GFAP into filaments and 
that the inhibitory effect of S-100 protein on GFAP assem- 
bly [15] is dependent upon blockade of the progression 
from GFAP tetramers to larger oligomers. Through a 
similar mechanism S-100 protein might stimulate ex- 
change of dimers between the polymerized and unpoly- 
merized state, and when present in sufficient quantity, 
induce filament disassembly, as previously demonstrated 
[35]. 
Consistent with this hypothesis, when experiments were 
B A 
S-100 protein 
S-100a o
GFAP rod domain 
Headless GFAP 
Desmin 
Desmin rod domain 
Headless desmin 
DSS 
b o 
• • • 
D 
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a b c 
Fig. 3. Effects of S-100 (or and /3) and S-100a o on DSS-induced formation of GFAP rod domain, headless GFAP, native desmin, desmin rod domain, and 
headless desmin. (A) Conditions were as in Fig. 1A, except hat the GFAP rod domain was used. Additions are indicated. (B) Western blot analysis with 
an anti-S-100 (or and /3) of lane c in A. (C) Western blot analysis with an anti-S-100 (a  and /3) of headless GFAP pre-incubated with S-100 (~ and /3) 
and then exposed to DSS. (D) Western blot analysis with an anti-S-100 (a  and /3) of native desmin (lane a), desmin rod domain (lane b), and headless 
desmin (lane c) pre-incubated with S-100a o and then exposed to DSS. Desmin and S-100a o concentrations in the incubation mixture were 12 and 8 /xM, 
respectively. See Fig, 1 for symbol egend. The position of either S-100ot or S-100/3 or both is indicated by (~) .  The position of the GFAP rod domain is 
indicated by (0 )  in A. Additions are marked by (O). 
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repeated in the presence of  TRTK-12,  an S-100 (ce and f l )  
inhibitory pept ide [21,22], the format ion of  S -100:GFAP 
complexes was greatly inhibited, which is support ive of  
the hypothesis  that TRTK-12 's  occupat ion S-100 protein 
b inding site competes effect ively for S-100 prote in 's  ca- 
pacity to b ind and to modulate assembly of  GFAP.  A 
A 
[] 
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[ 
A 
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Annex in l I2 -p l l  2 • • • • • • 
GFAP • • • • • 
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Fig. 4. Interaction of annexin II2-pl 12 with native GFAP or the GFAP rod domain as investigated by chemical cross-linking. (A) GFAP (35 /xM) was 
incubated as described in Section 2.2, in the absence or presence of 16 /xM annexin II2-pll 2 plus or minus 12 /xM S-100 (ol and /3), as indicated. For 
comparison, lanes a and b contain the results of parallel cross-linking experiments performed with GFAP alone (lane a) or with GFAP and S-100 (ct and 
fl) (lane b). (B) Annexin II2-pl 12 (18 ~M) was exposed to DSS either in the absence of other protein species (lane a), after incubation with 15/xM S-100 
(a  and /3 ) (lane b) (no GFAP present in either case), after incubation with the GFAP rod domain (lane d), or after incubation with the GFAP rod domain 
in the presence of S-100 (a and /3) (lane e). Lane c shows the electrophoretic pattern of the GFAP rod domain after exposure to DSS in the absence of 
annexin II2-pll 2 and S-100 (a and /3). (C) Conditions were as in A and B, except hat proteins resolved by SDS-PAGE were transblotted onto 
nitrocellulose paper for immunostaining with an anti-annexin II antiserum. (D) Western blot analyses of the same proteins as in lane c in A (lane b) and as 
in lane d in A (lane a) performed with an anti-S-100 (t~ and /3) antiserum. The position of annexin II is indicated by (A); the position of the complex of 
one tool of annexin II plus one mole of p l 1 is indicated by (• ) ;  the position of a cross-linked annexin Ile-pl 12 species is indicated by (•  • ) ;  the position 
of large GFAP oligomers is indicated by ([]); the position of the 60-kDa GFAP:S-100 subunit complex is indicated by (• ) ;  the position of the 70 kDa 
GFAP:S-100 dimer complex is indicated by (•  • ); the position of GFAP rod domain is indicated by (O); the low molecular weight GFAP oligomers are 
indicated by ( [ ); the position of monoeric S-100 (or and /3) and pl 1 is indicated by (~) .  DSS was present throughout. Additions are marked by (O). 
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detailed study of effects of TRTK-12 on the capacity of 
S-100 (a  and /3) to bind to GFAP and to affect GFAP 
assembly-disassembly is presented in the accompanying 
report [20]. 
3.2. The S-IO0 protein binding site on GFAP is located in 
the N-terminal head domain of  GFAP and desmin 
Based upon these resuks and with knowledge of the 
distinct roles played by the head, rod and tail domains of 
type III IF subunits, including GFAP [1-7], we decided to 
investigate the interaction of S-100 protein with GFAP 
molecule which had been proteolytically processed to lack 
both the head and tail domains (effectively GFAP rod 
domain) or just the head domain (headless-GFAP). Rele- 
vant to our investigations were previous studies which 
demonstrated that while the "rod domain" of type III IF 
subunits permits self-association of subunits up to the 
tetrameric form, the N-ternfinal head appears essential for 
progression of self-association from the stage of tetramers 
to that of high molecular weight oligomers and filaments 
[1-7]. For example, post-translational modifications (e.g. 
phosphorylation) of residues in the N-terminal head of 
type III IF subunits results in inhibition of assembly 
[24,36-40], and headless type III IF subunits fail to assem- 
ble [32]. Hence, since S-100 protein reduced the amount of 
the large GFAP oligomers formed in the presence of DSS 
and could be immunologically detected as a complex with 
monomeric GFAP and the low molecular weight GFAP 
oligomers, (Fig. 2A and B), we speculated that S-100 
protein might interact with the GFAP N-terminal head to 
produce its effects on GFAP assembly, i.e. inhibition of 
assembly and stimulation of disassembly. To test this 
possibility, GFAP was subjected to mild chymotrypsiniza- 
tion as reported [31] prior to exposure to S-100 protein and 
then DSS. It is known thai: mild chymotrypsinization pro- 
duces the cleavage of both the N-terminal head and C- 
terminal tail of GFAP [31]. The GFAP rod domain thus 
formed is presented in Fig. 3A, lane a. Identical elec- 
trophoretic patterns were obtained upon exposure to DSS 
of the rod domain of GFAP, irrespective of the presence or 
absence of S-100 protein in the incubation medium (Fig. 
3A, lanes b and c) and no S-100 immunological reaction 
could be detected above the stage of S-100 dimer-tetramer 
under these conditions (Fip. 3B). Also, GFAP rod domain 
was capable of forming to a limited degree low, but not 
high molecular weight complexes upon exposure to DSS 
(Fig. 3A, lane b), confirmiag that the rod domain of GFAP 
can self-associate up to the formation of tetramers, but 
self-association cannot proceed beyond this stage under 
these conditions. These data suggested that S-100 protein 
does not interact with tile rod domain of GFAP and, 
therefore, that the S-100 binding site on GFAP should be 
located in either the N-tenninal head or the C-terminal tail 
of GFAP. 
To distinguish between these two possibilities, GFAP 
was treated with thrombin to generate headless-GFAP [32] 
and the above cross-linking experiments were repeated. 
Western blot analyses howed that no S-100 protein im- 
munoreactivity was present in the molecular weight range 
from 40 kDa to higher values (Fig. 3C). 
Essentially identical results were obtained with desmin 
(Fig. 3D). Specifically, whereas S-100a o immunoreactivity 
was detected at the level of three closely spaced 65-75-kDa 
bands resulting from the formation of desmin: S-100c~- 
complexes and of low molecular weight desmin oligomers 
(Fig. 3D, lane a), no S-100c~ immunoreactivity was ob- 
served with desmin rod domain or headless desmin (Fig. 
3D, lanes b and c, respectively). S-100a o was used in the 
present cross-linking experiments with desmin since previ- 
ous work has shown that S-100 proteins bind to and affect 
the assembly of desmin with different potencies, i.e. S- 
100c~ >> S-100/3 >> calcyclin (S-100A6) > p l l  (S- 
100A10) [16]. Together, the present data strongly sup- 
ported our conclusion [20] that the S-100 (/3 and/or a)  
binding site is localized to the N-terminal head domain in 
GFAP and desmin. 
3.3. The annexin I Ie-pl l  2 binding site on GFAP is located 
on GFAP rod domain 
These experiments were repeated using the annexin 
II2-pll 2 heterotetramer, instead of S-100 protein (Fig. 4). 
Annexin II2-pll 2 favored DSS-induced the formation of 
GFAP-GFAP complexes, as demonstrated by the decrease 
in the amount of monomeric GFAP and increase in the 
intensity of (i) Coomassie blue staining material in the 
100-400-kDa range and (ii) large GFAP oligomers (com- 
pare lane c with lane a in Fig. 4A). Judging from the 
intensity of Coomassie blue-stained bands, the contribution 
of DSS-cross-linked annexin II2-pl 12 was minimal (Fig. 
4B, lane a). These results agreed with previous reports of 
the capacity of annexin II2-pl 1 z to promote GFAP assem- 
bly under conditions where assembly is hampered (e.g. at 
alkaline pH values) [17]. 
The presence of S-100 (a  and /3) in the incubation 
mixture containing GFAP and annexin II2-pll 2 did not 
change the electrophoretic pattern to a great extent, and the 
formation of the 60-kDa GFAP:S-100 subunit complex did 
not appear to be influenced by the presence of annexin 
II2-pl 12 (Fig. 4A, lane d), in accordance with the finding 
that S-100 (c~ and /3) and annexin II2-pll z bind to 
different sites on GFAP, as investigated by fluorescent 
spectroscopy [41]. Likewise, the presence of S-100 protein 
did change the electrophoretic pattern of the annexin II 2- 
pl 12 heterotetramer exposed to DSS (Fig. 4B, lane b). 
In immunoblot blot analyses anti-annexin II antiserum 
recognized monomeric annexin II, a ~ 45-kDa band likely 
corresponding to a DSS-induced complex of one copy of 
annexin II and one copy of pl 1, and a relatively faint band 
probably corresponding to a DSS-induced complex of two 
copies of annexin II plus two copies of pl 1 (Fig. 4C, lane 
274 M. Garbuglia et al. / Biochimica et Biophysica Acta 1313 (1996) 268-276 
a). In addition, faint annexin II immunoreactive bands 
were also detected in the range of 50-400 kDa and 
annexin II immunoreactivity was observed in association 
with the large GFAP oligomers when annexin II2-pll 2 
had been previously exposed to GFAP (Fig. 4C, lane b) 
and the presence of S-100 protein in the incubation mix- 
ture did not change the annexin II immunostaining pattern 
to a significant extent (Fig. 4C, lane c). 
Similar analyses determined S-100 (c~ and/3) immuno- 
reactivity to be associated with the large GFAP oligomers, 
in addition to the typical S-100 immunoreactivity detected 
at the level of the 60-kDa GFAP:S-100 subunit complex 
and complexes of relatively higher molecular weight (Fig. 
4D, lane a), suggesting that S-100 (a  and /3) remained 
associated with GFAP despite the presence of annexin 
II2-pl 12 and that annexin II2-pl 12 stimulated the DSS-in- 
duced cross-linking of GFAP:S- 100 complexes. 
Annexin II2-pll 2 stimulated the formation of DSS- 
cross-linked species when the GFAP rod domain was used 
instead of native GFAP (Fig. 4B, lane d), suggesting 
annexin II2-pll 2 binds to the GFAP rod domain. The 
presence of S-100 (c~ and /3) in incubation mixtures 
containing annexin II2-pl 12 and the GFAP rod domain did 
not change the electrophoretic pattern (Fig. 4B, lane e). 
Western blot analyses documented the presence of annexin 
II immunoreactivity in association with DSS-induced 
GFAP oligomers when the GFAP rod domain (Fig. 4C, 
lane e) or headless GFAP (not shown) had been used. The 
presence of S-100 (a  and/3) in the incubation mixture did 
not produce appreciable changes in the annexin II 
immunostalning pattern (Fig. 4C, lane f). Monomeric an- 
nexin II did not associate with either native GFAP or the 
GFAP rod domain in cross-linking experiments (data not 
shown), in accordance with previous results indicating that 
the annexin II2-Pl 12 heterotetramer, but not monomeric 
annexin II significantly interacts with GFAP and affects 
GFAP assembly [17]. By contrast, no interaction between 
annexin II2-pll 2 and desmin, desmin rod domain, or 
headless desmin, and no effects of annexin II2-pll 2 on 
desmin assembly could be documented (not shown). 
4. Discussion 
IF subunits are made of a central, helical rod domain 
flanked by an N-terminal head and a C-terminal tail do- 
main [1-7]. Whereas the rod domain is important for 
dimerization of IF subunits, the N-terminal head domain 
appears essential for progression from the stage of dimers 
to that of large IF oligomers. Consistent with this hypothe- 
sis are studies demonstrating that post-translational modifi- 
cation (e.g. phosphorylation) of residues or proteolytic 
removal of the N-terminal head domain results in assembly 
incompetent IF subunits [1-7,31,32]. While phosphoryla- 
tion is considered to be an important means of regulating 
IF dynamics, it is conceivable that protein factors might 
have a role in the regulation of IF assembly-disassembly 
simply by binding to IF subunits. We have demonstrated 
that members of the S-100 family (S-100/3 and/or S- 
100a) bind to the IF subunits GFAP and desmin thereby 
inhibiting their assembly and promoting their disassembly 
with various degrees of potency in a dose- and Ca 2+-de- 
pendent manner [15,16,35]. S-100 proteins stoichiometri- 
cally inhibit GFAP or desmin assembly by interfering with 
the nucleation and elongation of IF. We also documented 
that annexin II2-pll 2 stimulates GFAP assembly under 
conditions where assembly is unfavored, e.g. at alkaline 
pH values, and that S-100 proteins and annexin II2-pl 12 
might act in concert o regulate the GFAP IF dynamics 
[17,42]. 
In the current study we have localized the S-100 protein 
(/3 and/or a)-binding site on GFAP and desmin on the 
N-terminal head domain of each of these IF subunits and 
presented evidence indicating that S-100 proteins interfere 
with the progression from the stage of GFAP or desmin 
dimers/tetramers to that of larger oligomers by binding to 
that site. 
Several ines of evidence support he above conclusion: 
(i) S-100 (a  and /3) produce remarkable changes in the 
amounts of DSS-cross-linked GFAP species such as a 
decrease in the fraction of large GFAP oligomers and an 
increase in GFAP dimers, trimers and tetramers; (ii) by the 
same experimental pproach, S-100 (a  and /3) immuno- 
reactivity is found associated with GFAP dimers, trimers 
and tetramers, and, to a larger extent, with a 60-kDa 
GFAP:S100 subunit complex, but not with large GFAP 
oligomers; (iii) chemical cross-linking experiments per- 
formed in the presence of increasing urea concentrations 
show that S-100 (a  and /3) produce a decrease in the 
fraction of GFAP tetramers and an increase in the fraction 
of GFAP dimers; (iv) under the same conditions, the 
60-kDa GFAP:S-100 subunit complex forms in the pres- 
ence of up to 6-8 M urea; (v) S-100 (/3 and/or a)  do not 
interact with the GFAP or desmin rod domain, or with 
headless GFAP or desmin. Together these observations 
suggest that S-100 (a and /3) interfere with the ability of 
DSS to cross-link GFAP subunits by binding to and chang- 
ing the conformation of GFAP, that S- 100 (a  and /3) bind 
to a sequence in GFAP that is not influenced by the 
denaturing agent, urea, to a large extent, that this sequence 
is located in GFAP N-terminal head, and that the GFAP 
binding site on S-100a and S-100/3 also should corre- 
spond to a sequence that is not greatly influenced by high 
urea concentrations. Chemical crosslinking and Western 
blot analyses indicate that the same applies to desmin as 
far as S-100a o is concerned, suggesting that S-100 (/3 
and/or c~) bind to a site shared by GFAP and desmin and, 
conversely, that GFAP and desmin share a binding site on 
S-100 (/3 and/or c~). 
The sequence SSYRRIFGG that is found at just the 
beginning of desmin or vimentin sequence is considered 
critical for desmin or vimentin assembly [43,44]. It is 
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suggested that the sequence MERRITS-ARRSY, that is 
found at the beginning of the GFAP sequence shares ome 
characteristics with the above sequence [45]. However, the 
sequence RLSL-RM-PP, termed RP-box motif, that has 
been identified in the N-terminal head of GFAP just prior 
to the GFAP rod domain and shares some characteristics 
with an analogous sequence in the N-terminal head domain 
of desmin or vimentin also is considered critical for GFAP 
assembly and, by analogy, for desmin or vimentin assem- 
bly [45]. The accompanying report [20] documents hat the 
S-100 (c~ and /3) inhibitory peptide TRTK-12 [21,22] 
blocks the ability of S-100 (a  and /3) to bind to GFAP 
and to affect GFAP assembly-disassembly. This report [20] 
also shows that a 121 amino acid segment 
(31PGTRLSLARMPPPLPTRVDFSs~) contained within the 
GFAP N-terminal head domain and comprising the RP-box 
motif [45] exhibits trong homology to a set of S-100-bind- 
ing peptides on the basis of which TRTK-12 had been 
synthesized [21,22]. Thus, the S-100 (/3 and/or ce) bind- 
ing site on GFAP or desmin might be located in the above 
21 amino acid segment of GFAP and in a corresponding 
segment contained within desmin N-terminal head. Future 
analyses will hopefully confirm this suggestion. At pre- 
sent, we can conclude that occupation by S-100 (/3 and/or 
c~) of a site on the N-terminal head domain of unassem- 
bled GFAP and desmin that is critical for IF formation 
blocks GFAP and desmin assemblies and produces IF 
disassembly. Consistent with this interpretation is the find- 
ing that S-100 (/3 and/or c~) interfere with both the 
nucleation and elongation of GFAP and desmin IFs 
[15,16,35,42]. 
We have also determined that the annexin II2-pll 2 
heterotetramer binds to GFAP rod domain. Annexin II 2- 
p l l  2 was shown to co-sediment with GFAP IFs and to 
stimulate GFAP assembly under conditions, e.g. at alkaline 
pH values, in which GFAP assembly is strongly reduced, 
as investigated by several experimental pproaches includ- 
ing electron microscopy [17,41,42]. Since annexin II2-Pl 12 
favors the formation of DSS-cross-linked GFAP oligomers, 
irrespective of whether native GFAP or the GFAP rod 
domain is being tested, we conclude that annexin II2-Pl 12 
affects GFAP assembly by interacting with its rod domain. 
These data confirm previous observations indicating that 
S-100 (~ and /3) and annexin II2-pl 12 produce different 
conformational changes in GFAP as investigated by fluo- 
rescent spectroscopy [41]. Under the present experimental 
conditions, annexin II2-pl 12 favors the formation of DSS- 
crosslinked GFAP species even in the presence of S-100 
proteins, again suggestive of the discrete nature of the 
S-100 (c~ and /3) and armexin II2-pll 2 protein binding 
sites on GFAP. Also, the present data indicate that S-100 
(t~ and /3) remain associated with both low and high 
molecular weight DSS-cross-linked GFAP oligomers in 
the presence of annexin II?.-pl 12, suggesting that effects of 
annexin II2-pl 12 on GFAP leave the GFAP:S-100 protein 
interactions undisturbed. Together, these results support 
the possibility that S-100 (oz and /3) and annexin II2-pll 2 
might act in concert o regulate GFAP IF dynamics in glial 
cells [42]. 
The rod domain of IF subunits is considered important 
for subunit dimerization [1-7]. At present no data are 
available on the identification of the annexin IIz-pll 2 
binding site on the GFAP rod domain. We can only 
speculate that binding of annexin IIe-pll 2 to that domain 
might produce changes in the net negative charge of GFAP 
or, in any case, in the charge of the rod domain, that result 
in strengthening of GFAP-GFAP associations. The in- 
hibitory effect of phosphorylation GFAP assembly was 
ascribed to a decrease in the net positive charge of the 
GFAP N-terminal head [24]. Recently, GFAP was reported 
to exist mostly as tetramers in buffers of low ionic strength 
and that the fraction of GFAP dimers increases at alkaline 
pH values [46]. By contrast, no such effects of pH could be 
observed with vimentin [47] or desmin [46]. One possibil- 
ity is that association of annexin II2-pll 2 with GFAP 
dimers favors the aggregation of these dimers into te- 
tramers or higher oligomers by decreasing the negative 
charge of GFAP. Interestingly, annexin II2-pl 12 does not 
interact with or affect desmin assembly, likely due to the 
above mentioned insensitivity of desmin to pH changes. 
Future analyses hould prove or disprove the above specu- 
lation. 
In conclusion, we provide herein evidence that proteins 
of the S-100 family interact with a sequence contained in 
the N-terminal head domain of both GFAP (S-100c~ and 
S-100/3, in this case) and desmin (S-100c~), whereas 
annexin II2-pll 2 interacts with the GFAP rod domain. 
Calcium is required for these interactions to occur, since 
no binding of S-100 proteins to GFAP or desmin or of 
annexin II2-pll 2 to GFAP was evident in the absence of 
free Ca 2+ or when mixtures were incubated in the pres- 
ence of Ca 2+ and then excess EGTA was added before 
DSS (data not shown). This indicates that S-100 (c~ and 
/3) and annexin IIe-pl 12 represent likely CaZ+-dependent 
regulators of IF dynamics and that subsequent to the 
elevation of the free Ca 2÷ concentration, i.e. upon appro- 
priate cell stimulation, they modulate IF assembly-disas- 
sembly. 
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